About This Project
Rabies infection is almost always fatal in humans. The current treatment for a bite from a rabid animal (injection of human serum from immunized people) is often in short supply, especially in developing world settings. We aim to find antibodies from a rabies-vaccinated donor, using blood taken just weeks after vaccination. By sequencing the antibody genes present in these cells, we can make antibodies, providing less expensive and readily available treatment for the virus.